Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.68
-1.06%
Mkt Cap $5.95M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+339.4%
Consensus $3.00 vs current $0.68
NASDAQ·Healthcare·Biotechnology
$0.68
-1.06%
Mkt Cap $5.95M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+339.4%
Consensus $3.00 vs current $0.68